Skip to main content

Surmodics Inc

SRDXDelisted Nov 19, 2025
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000924717

Surmodics Inc was delisted on Nov 19, 2025; its insiders filed their last Form 4 on Nov 19, 2025; 146 institutions reported holding it in 13F filings for Q3 2025, worth $345.2M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Surmodics Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of SRDX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders1171112−4
Shares13.1M10.6K12.7M−326.2K (−2.5%)
Value$475.0M$386.3K$373.3M−$101.3M (−21.3%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Surmodics Inc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SRDX in Q1 2024
InstitutionSharesValue% of portfolio
Healthcare of Ontario Pension Plan Trust Fund43,300$1.27M0.00%
Sierra Summit Advisors LLC18,792$551.4K0.15%
Cetera Investment Advisers17,186$504.2K0.00%
Sherbrooke Park Advisers LLC11,580$339.8K0.07%
Catalyst Funds Management Pty Ltd10,340$303.4K0.08%
Squarepoint Ops LLC9,955$292.1K0.00%
Man Group plc9,389$275.5K0.00%
Envestnet Asset Management Inc8,016$235.2K0.00%
Point72 (DIFC) Ltd286$8.39K0.00%
Signaturefd, LLC191$5.60K0.00%
Aquatic Capital Management LLC100$2.93K0.00%
Covestor Ltd21$1.00K0.00%
GAMMA Investing LLC20$5870.00%

Sold out (17)

Institutions that held Surmodics Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (1)

Institutions that held Surmodics Inc at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SRDX in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Putnam Investments LLC10,628$386.3K